HS
VIVO

Horan Securities’s Meridian Bioscience Inc VIVO Stock Holding History

Horan Securities’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,416
Closed -$47K – 845
2022
Q4 		$47K Hold
1,416
– – 0.03% 213
2022
Q3 		$45K Hold
1,416
– – 0.03% 191
2022
Q2 		$46K Sell
1,416
-200
-12% -$5.41K 0.03% 178
2022
Q1 		$42K Hold
1,616
– – 0.02% 193
2021
Q4 		$33K Buy
+1,616
New +$31K 0.02% 206
2021
Q2 		$36K Buy
1,616
+425
+36% +$9.02K 0.03% 194
2021
Q1 		$31K Hold
1,191
– – 0.03% 186
2020
Q4 		$22K Hold
1,191
– – 0.02% 186
2020
Q3 		$20K Sell
1,191
-200
-14% -$3.89K 0.02% 169
2020
Q2 		$32K Hold
1,391
– – 0.04% 97
2020
Q1 		$12K Buy
+1,391
New +$11.7K 0.02% 125
2019
Q4 		– Sell
-1,391
Closed -$13K – 241
2019
Q3 		$13K Hold
1,391
– – 0.01% 143
2019
Q2 		$17K Hold
1,391
– – 0.02% 137
2019
Q1 		$25K Buy
1,391
+10
+0.7% +$166 0.03% 103
2018
Q4 		$23K Buy
1,381
+9
+0.7% +$153 0.03% 102
2018
Q3 		$21K Buy
1,372
+12
+0.9% +$186 0.02% 93
2018
Q2 		$21K Buy
1,360
+12
+0.9% +$179 0.02% 93
2018
Q1 		$20K Buy
+1,348
New +$19.9K 0.02% 87

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Horan Securities's VIVO Position: Q1 2023 in Review

Horan Securities sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 1,416 shares — an estimated $47K sold.

Horan Securities first reported a position in VIVO in Q1 2018 and held it in 18 quarters. The position peaked at $47K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Horan Securities reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Horan Securities sold 1,416 Meridian Bioscience Inc shares in Q1 2023, an estimated $47K.
  • Horan Securities first reported a position in Meridian Bioscience Inc in Q1 2018 and held it in 18 quarters.
  • Horan Securities's Meridian Bioscience Inc position peaked at $47K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Horan Securities's 13F filing for Q1 2023, filed 18 Apr 2023.